Patent · US Expired

Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules

US5741893A · kind A · utility

21Cited by
48References
8Claims
0Family size

Inventor

Key dates

Filing dateJun 7, 1995
Grant dateApr 21, 1998
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/829
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and processes to alleviate free radical toxicity are disclosed based on the use of nitroxides in association with physiologically compatible macromolecules. In particular, hemoglobin-based red cell substitutes are described featuring stable nitroxide free radicals for use in cell-free hemoglobin solutions, encapsulated hemoglobin solutions, stabilized hemoglobin solutions, polymerized hemoglobin solutions, conjugated hemoglobin solutions, nitroxide-labelled albumin, and nitroxide-labelled immunoglobulin. Formulations are described herein that interact with free radicals, acting as antioxidant enzymemimics, which preserve nitroxides in their active form in vivo. Applications are described including blood substitutes, radioprotective agents, imaging agents, agents to protect against ischemia and reperfusion injury, and in vivo enzyme mimics among others.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.